InvestorsHub Logo
Followers 43
Posts 5535
Boards Moderated 0
Alias Born 11/15/2013

Re: None

Thursday, 05/21/2020 10:44:22 AM

Thursday, May 21, 2020 10:44:22 AM

Post# of 403507
SEC 8-k filing- Item 7.01. Regulation FD Disclosure

On May 19, 2020, Innovation Pharmaceuticals Inc. issued a press release titled, Innovation Pharmaceuticals’ Brilacidin Reduces Viral Titer of SARS-CoV-2 (COVID-19) by 75 percent After Only 1 Hour of Preincubation in In Vitro Study at BSL-3 Facility; Demonstrates Potent and Rapid Virucidal Activity.

On May 21, 2020, Innovation Pharmaceuticals Inc. issued a shareholder alert titled, Pursuing the Gold Standard in the Battle Against SARS-CoV-2 (Covid-19).